Related Experiment Video
Updated: May 2, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Campylobacter concisus and inflammatory bowel disease.
Li Zhang1, Hoyul Lee1, Michael C Grimm1
1Li Zhang, Hoyul Lee, School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
Campylobacter concisus (C. concisus) may trigger inflammatory bowel disease (IBD) by producing a toxin that increases intestinal permeability. This oral bacterium
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Campylobacter concisus (C. concisus) is increasingly associated with inflammatory bowel disease (IBD).
- The mechanism by which oral C. concisus contributes to gut inflammation remains unclear.
- Increased intestinal permeability is a hallmark of IBD.
Purpose of the Study:
- To investigate the role of C. concisus in IBD pathogenesis.
- To explore the potential mechanism involving the zonula occludens toxin (zot).
Main Methods:
- Review of existing evidence on C. concisus, zot, and IBD.
- Comparative analysis of C. concisus Zot with Vibrio cholerae Zot and human zonulin.
- Assessment of the impact on intestinal tight junctions and permeability.
Main Results:
- Some C. concisus strains possess the zonula occludens toxin (zot) gene acquired from a prophage.
- C. concisus Zot shares functional motifs with known intestinal permeability-increasing proteins.
- These toxins affect tight junctions, potentially increasing intestinal permeability.
Conclusions:
- C. concisus Zot may induce intestinal barrier dysfunction.
- This barrier defect is a proposed mechanism linking zot-positive C. concisus to IBD onset and relapse.
- Further research into C. concisus as an IBD trigger is warranted.
More Related Videos
11:04The Citrobacter rodentium Mouse Model: Studying Pathogen and Host Contributions to Infectious Colitis
Published on: February 19, 2013
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis